These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 8289991

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Low-dose simvastatin is a well-tolerated and efficacious cholesterol-lowering agent in ciclosporin-treated kidney transplant recipients: double-blind, randomized, placebo-controlled study in 40 patients.
    Arnadottir M, Eriksson LO, Germershausen JI, Thysell H.
    Nephron; 1994; 68(1):57-62. PubMed ID: 7991041
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Rhabdomyolysis and acute renal failure in a cardiac transplant recipient due to multiple drug interactions.
    Kusus M, Stapleton DD, Lertora JJ, Simon EE, Dreisbach AW.
    Am J Med Sci; 2000 Dec; 320(6):394-7. PubMed ID: 11149552
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Rhabdomyolysis caused by simvastatinin a patient following heart transplantation and cyclosporine therapy].
    Blaison G, Weber JC, Sachs D, Korganow AS, Martin T, Kretz JG, Pasquali JL.
    Rev Med Interne; 1992 Dec; 13(1):61-3. PubMed ID: 1410877
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of sustained/controlled-release dosage forms of 3-hydroxy-3-methylglutaryl-coenzyme a (HMG-CoA) reductase inhibitors in dogs and humans.
    Cheng H, Sutton SC, Pipkin JD, Zentner GM, Rogers JD, Schwartz JI, Mitchel YB, Grasing K, Schwartz MS, Amin RD.
    Pharm Res; 1993 Nov; 10(11):1683-7. PubMed ID: 8290485
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS, Bacon SP, Illingworth DR.
    J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Drug-interaction-induced rhabdomyolysis.
    Segaert MF, De Soete C, Vandewiele I, Verbanck J.
    Nephrol Dial Transplant; 1996 Sep; 11(9):1846-7. PubMed ID: 8918636
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Determination of the HMG-CoA reductase inhibitors simvastatin, lovastatin, and pravastatin in plasma by gas chromatography/chemical ionization mass spectrometry.
    Morris MJ, Gilbert JD, Hsieh JY, Matuszewski BK, Ramjit HG, Bayne WF.
    Biol Mass Spectrom; 1993 Jan; 22(1):1-8. PubMed ID: 8431499
    [Abstract] [Full Text] [Related]

  • 17. Effect of simvastatin on qualitative and quantitative changes of lipoprotein metabolism in CAPD patients.
    Wanner C, Lubrich-Birkner I, Summ O, Wieland H, Schollmeyer P.
    Nephron; 1992 Jan; 62(1):40-6. PubMed ID: 1436290
    [Abstract] [Full Text] [Related]

  • 18. Long-term clinical tolerance of lovastatin and simvastatin.
    Bilheimer DW.
    Cardiology; 1990 Jan; 77 Suppl 4():58-65. PubMed ID: 2073673
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.